Enrico Scala is an expert in Immunology at Istituto Dermopatico dell'Immacolata (Italy). As of October 2026, ScienceLeadR ranks Enrico Scala in the top 1% of experts worldwide for Hypersensitivity. Enrico Scala has authored 215 publications, the most recent in 2026, and is an investigator in 1 clinical trial. SLR score: 672 (community average: 125). How the SLR is computed.

LeadR Profile

672 ScienceLeadR Reputation 672
Network Map

Immunology

Subspecialties: Dermatology - Allergy - Nutrition

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1992 - 2026

Source: PubMed

Istituto Dermopatico dell'Immacolata

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 215

Citations

Citations: 10 947 1st author: 58 Last author: 16 Unique author: 2


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Hazelnut and Walnut Vicilins in Tree Nut Allergy: Co-Sensitization Patterns and Clinical Severity Associations.
PMID 42584216 — hypersensitivity, nuts, seeds, seed storage proteins, nut hypersensitivity, sex, allergy
Allergy20261
Mutational profile of atypical fibroxanthoma and pleomorphic dermal sarcoma further expands the spectrum of genomic alterations in rare cutaneous neoplasms.
PMID 42071062 — genes, neoplasms, sarcoma, neoplasm metastasis, natural science disciplines, mutation
Sci Rep20260
CXCL13 as a simple and promising blood biomarker for differentiating Sézary syndrome from mycosis fungoides and other confounding chronic inflammatory skin diseases.
PMID 42039158 — skin, cells, research design, mycosis fungoides, blood, sezary syndrome, skin diseases, biomarkers, plasma
Front Immunol20260
Genetic profiling of patients with atopic dermatitis reveals immune and skin barrier variants associated with generalized eczema and optimal response to Dupilumab therapy.
PMID 42039188 — skin, genes, comorbidity, dermatitis, eczema, phenotype, therapeutics, asthma, dermatitis, atopic
Front Immunol20260
Algorithms in Allergy: Diagnosis and Treatment of Pollen Food Syndrome.
PMID 41792853 — food hypersensitivity, hypersensitivity, algorithms, food, diagnosis, therapeutics, allergy
Allergy20260

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 1

By status:

Completed 1

By type:

Interventional 1

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 0
multicentric5to9 0
multicentricup10 1

Main Topics

LeadR Networks

Main global connection map